Abstract
If one wishes to examine, in a thoroughly objective manner, the results of chemotherapy on solid tumours, based on valid criteria such as the duration of survival of treated patients compared to untreated patients, one is led to the conclusion that they are collectively very poor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amiel, J. L., A. M. Mery et G. Mathe: Les réponses immunitaires chez les patients atteints de choriocarcinome placentaire. Corrélation entre ces réponses et l’évolution de la maladie. Symp. on “Cell bound immunity with special reference to antilymphocyte serum and immunotherapy of cancer”. 1 vol. Liège: Université de Liège, 1967.
Amiel, J. L., M. Sekiguchi, G. Daguet, S. Garattini et V. Palma: Étude de l’effet immunodépresseur des composés chimiques utilisés en chimiothérapie anticancéreuse. J. Europ. Cancer 3, 47 (1967).
Barnes, D. W. H., C. E. Ford, S. M. Gray, and J. F. Loutit: Spontaneous and induced changes in cell populations in heavily irradiated mice. Prog. Nuclear Energy 2, 1 (1959).
Bergsagel, D. E.: Personal communication.
Brennam, M. J., R. W. Talley, E. L. San Diego, J. H. Burrows, R. M. O’Bryan, V. K. Waitkevicius, and S. Horeglad: Critical analysis of 594 cancer patients treated with 5-fIuorouracil, p. 118. In: Chemotherapy of cancer, 1 vol. Amsterdam: Elsevier 1964.
Broome, J.D.: Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J. exp. Med. 118, 99 (1963).
Bruce, W. R., and B. E. Meeker: Comparison of the sensitivity of normal hemopoietic and transplanted lymphoma colony forming cells to tritiated thymidine. J. nat. Cancer Inst. 34, 849 (1965).
——— ———, and F. Valeriotte: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. nat. Cancer Inst. (1968) in press.
Buinauskas, P., G. O. McDonald, and W. H. Cole: Role of operative stress on the resistance of the experimental animal to inoculated cancer cells. Ann. Surg. 184, 642 (1958).
Cachin, Y., J. Richard, R. Gerard-Marchant et C. Vandenbrouk: Chimiosensibilité élective d’un type d’épithélioma particulier des voies aéro-digestives supérieures, la kératose villeuse maligne. Ann. Carc. Cerv. Fac. 1, 81 (1967).
Chirigos, M. A., J. Colsky, S. R. Humphreys, J. P. Glynn, and A. Goldin: Evaluation of surgery and chemotherapy in the treatment of mouse mammary adenocarcinoma 755. Cancer Chemother. Rep. 22, 49 (1962).
Cole, W. H., R. G. Mrazek, S. G. Economou, G. O. McDonald, D. P. Slaughter, and F. W. Strehl: Adjuvant chemotherapy. Cancer 18, 1529 (1965).
Curreri, A. R., F. J. Ansfield, F. A. McIver, H. A. Waisman, and C. Heidelberger: Clinical studies with 5-fluorouracil. Cancer Res. 18, 478 (1958).
Ferrer, F. J., and E. Mihich: Antitumor effects of kethoxal-bis (thiosemicarbazone) and 6-mercaptopurine in neonatally thymectomised mice. Proc. Soc. exp. Biol. Med. 124, 939 (1967).
Frei, E., and E. J. Freireich: Progress and perspectives in the chemotherapy of acute leukaemia, p. 269. In: Advances in chemotherapy, vol. 2. New York: Acad. Press 1965.
Goldacre, R. J., and M. E. Whisson: The biology of large tumours regressing with nitrogen mustard treatment: a study of the mouse plasma cell tumour ADJ-PC-5 and walker carcinosarcoma 256. Brit. J. Cancer 20, 801 (1966).
Griffiths, J. D., and A. J. Salsbory: The circulating cancer cell. Springfield: Acad. Press 1965.
Hertz, R., J. Lewis, and M. B. Lipsett: Five years experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumours in women. Amer. J. Obst. Gynec. 82, 631 (1961).
Holland, J. F.: Intensive high dose treatment of children in complete remission of acute lymphocytic leukemia, p. 163. In: Chemotherapy of Burkitt’s tumor, 1 vol. J. H. Burchenal and D. Burkitt (Ed,). Berlin-Heidelberg-New York: Springer 1967.
Karrer, K., and S. R. Humphreys: Adjuvant chemotherapy given before or after surgery. Proc. Amer. Ass. Cancer Res. 8, 35 (1967).
Kidd, J. G: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Courses of transplanted cancer of various kinds in mice and rats given guinea pig serum, horse serum or rabbit serum. J. exp. Med. 98, 565 (1953).
Klein, G, P. Clifford, E. Klein, and J. Stjernsward: Search for tumour specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Symp. U.I.C.C. on Burkitt’s tumor, Uganda, 1966. Berlin-Heidelberg-New York: Springer 1967.
Martin, D. S., and R. A. Fugmann: Clinical implications of the interrelationship of tumor size and chemotherapeutic response. Ann. Surg. 151, 97 (1960).
Mathé, G: La dernière cellule. Presse méd. 75, 2591 (1967).
——— L’immunothérapie des cancers. Presse méd. 75, 947 (1967).
———, J. Dausset, E. Hervet, J. L. Amiel, J. Colombani, and G. Brule: Immunological studies in patients with placental choriocarcinoma. J. nat. Cancer Inst. 33, 193 (1964).
Mathé, G., M. Hayat, L. Schwarzenberg, J. L. Amiel, M. Schneider, A. Cattan, J. R. Schlumberger, and C. Jasmin: Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine and rubidomycine. Lancet 1967, II, 380.
———, L. Schwarzenberg, M. Hayat et M. Schneider: Chimiothérapie de la leucémie L 1210: comparaison pour 7 composés, des effets de l’administration continue sur 20 jours, et de l’administration d’une dose unique massive, précoce ou tardive. Rev. Fr. Et. Clin. Biol., 13, 951 (1968).
——— ——— ——— Dose de cyclophosphamide, action antileucémique et effet immuno-inhibiteur. Rev. Fr. Et. Clin. Biol. 13, 695 (1968).
—, J. L. Amiel, A. Cattan, J. R. Schlumberger et A. Flaisler: Chimiothérapie anticancéreuse intensive; transfusion de moelle osseuse autologue; chambres exemptes de germes pathogènes. Presse méd. 74, 2615, (1966).
———, O. Schweisguth, G. Brule, J. L. Amiel, A. Cattan, M. Thomas et P. Zamet: Essai de traitement de la maladie de Hodgkin et d’autres affections réticulo-histiocytaires malignes par la vincaleucoblastine. Presse méd. 70, 1349 (1962).
—, C. Brezin, J. L. Amiel, L. Schwarzenberg, M. Schneider, A. Cattan, C. Jasmin et R. Smadja: Essai de traitement par la leurocristine de la leucémie aigue lymphoblastique et du lymphoblastosarcome. Presse méd. 71, 529 (1963).
——— et al: Extrême chimiosensibilité de certaines tumeurs solides, contrastant avec la faible chimiosensibiHté habituelle. 1969, to be published.
Mihich, F.: Chimiothérapie anti-tumorale. Considérations sur le rôle potentiel de l’immunité. Path. Biol. 15, 209 (1967).
Moore, G. E., and C. A. Ross: Chemotherapy as an adjuvant to surgery. Ann. Rev. Med. 14, 141 (1963).
Oliviero, V. L, et C. G. Zubrod: Clinical pharmacology of the effective antitumor drugs. Ann. Rev. Pharmacol. 5, 335 (1965).
Salsbury, A. J.: Erasmus demonstration. Roy. Coll. Surg. England. 1966 (not published).
Schaudig, H.: Experiences with cytostatic treatment of cancer patients in surgery. Med. Welt 17, 2406 (1966).
Schneider, M.: Les défenses immunitaires des cancéreux. In preparation.
Schwarzenberg, L., G. Mathé, M. Hayat, F. de Vassal, J. L. Amiel, A. Cattan, M. Schneider, J. R. Schlumberger, C. Rosenfeld et C. Jasmin: Une nouvelle combinaison de méthotrexate-acide folinique pour le traitement des cancers (leucémies aigues et tumeurs solides). Presse Med. 77, 385 (1969).
Skipper, H. E., F. M. Schabel, and W. S. Wilcox: Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with “curability” of experimental leukaemia. Cancer Chemoth. Rep. 35, 3 (1964).
Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic concepts underlying chemotherapy of leukaemia. Cancer Chemoth. Rep. 45, 5 (1965).
——— ——— ——— Experimental evaluation of potential anticancer agents. XXI. Schedulling of arabinosylcytosine to take advantage of its S-phase specificity against leukaemia cells. Cancer Chemoth. Rep. 51, 125 (1967).
Stevens, J. E., and D. A. Willougby: Phytohemagglutinin and cell mediated hyper-sensibility reactions in rat. Nature 215, 967 (1963).
Veterans Administration Cooperative Surgical Adjuvant Study Group: Use of Thio-TEPA as an adjuvant to the surgical management of carcinoma of the stomach. Cancer 18, 291 (1965).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Mathé, G. (1969). Operational Research in Cancer Chemotherapy. Chemotherapy in the Strategy of Cancer Treatment. In: Mathé, G. (eds) Scientific Basis of Cancer Chemotherapy. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88147-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-88147-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88149-7
Online ISBN: 978-3-642-88147-3
eBook Packages: Springer Book Archive